{"transactions":[{"id":4634435,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-10-02T02:00:09.000Z","date":"2026-09-30","kind":"sale","planned":false,"acquired":false,"shares":3330,"price":29.2805,"value":97504.065,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $29.2800 to $29.2900. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."}],"balance_after":54790,"source":{"system":"sec-edgar","filing":"0001193125-26-410928","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526410928/ownership.xml","form_type":"4"}},{"id":4615477,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-09-11T00:30:08.000Z","date":"2026-09-09","kind":"grant","planned":false,"acquired":true,"shares":7217,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported securities represent restricted stock units which each entitle the reporting person to receive one common share of the Issuer. The restricted stock units will vest on September 9, 2027, subject to the reporting person's continued service through such date."}],"balance_after":58120,"source":{"system":"sec-edgar","filing":"0001193125-26-388306","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526388306/ownership.xml","form_type":"4"}},{"id":732533,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:07:33.000Z","date":"2026-06-17","kind":"grant","planned":false,"acquired":true,"shares":30864,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. \"Date of Grant\" shall mean June 17, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."}],"balance_after":66532,"source":{"system":"sec-edgar","filing":"0001193125-26-275834","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000119312526275834/ownership.xml","form_type":"4"}},{"id":825359,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-03-30T22:06:15.000Z","date":"2026-03-26","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":19.98,"value":199800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $19.82 to $20.02. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range."}],"balance_after":50903,"source":{"system":"sec-edgar","filing":"0001193125-26-132324","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000119312526132324/ownership.xml","form_type":"4"}},{"id":937097,"issuer":{"id":7318,"kind":"organization","name":"InspireMD, Inc.","symbol":"NSPR"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-16T23:09:21.000Z","date":"2026-01-14","kind":"grant","planned":false,"acquired":true,"shares":44030,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the \"One Year Grant Anniversary Date\"), subject to the Reporting Person's continued service."}],"balance_after":92417,"source":{"system":"sec-edgar","filing":"0001493152-26-002663","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1433607/000149315226002663/ownership.xml","form_type":"4"}},{"id":1045977,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-09-08T21:38:22.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":10909,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The reported securities in this row represent restricted stock units (\"RSUs\") which each entitle the Reporting Person to receive one common share of the Issuer.  The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported securities in this row represent restricted stock units (\"RSUs\") which each entitle the Reporting Person to receive one common share of the Issuer.  The RSUs will vest on September 4, 2026, subject to the Reporting Person's continued service through such date."}],"balance_after":40903,"source":{"system":"sec-edgar","filing":"0000950170-25-113631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000095017025113631/ownership.xml","form_type":"4"}},{"id":1045976,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-09-08T21:38:22.000Z","date":"2025-03-07","kind":"purchase","planned":false,"acquired":true,"shares":17000,"price":17,"value":289000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported securities in this row were purchased in connection with the Issuer's initial public offering reserved share program and were inadvertently omitted from the Reporting Person's prior filings."}],"balance_after":29994,"source":{"system":"sec-edgar","filing":"0000950170-25-113631","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000095017025113631/ownership.xml","form_type":"4"}},{"id":1076546,"issuer":{"id":1226,"kind":"organization","name":"RxSight, Inc.","symbol":"RXST"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-04T20:47:56.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":35668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of RxSight, Inc. Common Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to the Reporting Person's continuing service as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one third of the RSUs subject to the award shall vest on each annual anniversary of July 31, 2025."}],"balance_after":35668,"source":{"system":"sec-edgar","filing":"0000950170-25-102098","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1111485/000095017025102098/ownership.xml","form_type":"4"}},{"id":1082243,"issuer":{"id":4686,"kind":"organization","name":"KESTRA MEDICAL TECHNOLOGIES, LTD.","symbol":"KMTS"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-07-24T20:10:50.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":12994,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The Reporting Person previously held restricted Class A Common Units of West Affum Holdings, L.P. granted on July 24, 2024, which were automatically converted into 12,994 restricted common shares of the Issuer in connection with the Issuer's initial public offering. The restricted common shares vest into common shares of the Issuer. 4,331 restricted common shares held by the Reporting Person vested on July 24, 2025. Of the remaining restricted common shares held by the Reporting Person, 4,331 restricted common shares will vest on July 24, 2026 and 4,332 restricted common shares will vest on July 24, 2027."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person previously held restricted Class A Common Units of West Affum Holdings, L.P. granted on July 24, 2024, which were automatically converted into 12,994 restricted common shares of the Issuer in connection with the Issuer's initial public offering. The restricted common shares vest into common shares of the Issuer. 4,331 restricted common shares held by the Reporting Person vested on July 24, 2025. Of the remaining restricted common shares held by the Reporting Person, 4,331 restricted common shares will vest on July 24, 2026 and 4,332 restricted common shares will vest on July 24, 2027."}],"balance_after":12994,"source":{"system":"sec-edgar","filing":"0000950170-25-098339","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1877184/000095017025098339/ownership.xml","form_type":"4"}},{"id":1363468,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-15T13:59:03.000Z","date":"2024-11-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":106776,"price":69.37,"value":7407051.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of the Issuer's common stock granted under the Issuer's 2018 Omnibus Incentive Plan (f/k/a/ Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan) and the Axonics Modulation Technologies, Inc. 2014 Stock Incentive Plan (each such option, a \"Company Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (a) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Company Option and (b) the aggregate number of shares of the Issuer's common stock issuable upon exercise of such Company Option, less applicable taxes and authorized deductions"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of the Issuer's common stock granted under the Issuer's 2018 Omnibus Incentive Plan (f/k/a/ Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan) and the Axonics Modulation Technologies, Inc. 2014 Stock Incentive Plan (each such option, a \"Company Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (a) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Company Option and (b) the aggregate number of shares of the Issuer's common stock issuable upon exercise of such Company Option, less applicable taxes and authorized deductions"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of the Issuer's common stock granted under the Issuer's 2018 Omnibus Incentive Plan (f/k/a/ Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan) and the Axonics Modulation Technologies, Inc. 2014 Stock Incentive Plan (each such option, a \"Company Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (a) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Company Option and (b) the aggregate number of shares of the Issuer's common stock issuable upon exercise of such Company Option, less applicable taxes and authorized deductions"}],"balance_after":0,"derivative":{"exercise_price":1.63,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":106776},"source":{"system":"sec-edgar","filing":"0001562180-24-007702","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024007702/primarydocument.xml","form_type":"4"}},{"id":1363467,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-15T13:59:03.000Z","date":"2024-11-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":196451,"price":56.81,"value":11160381.31,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of the Issuer's common stock granted under the Issuer's 2018 Omnibus Incentive Plan (f/k/a/ Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan) and the Axonics Modulation Technologies, Inc. 2014 Stock Incentive Plan (each such option, a \"Company Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (a) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Company Option and (b) the aggregate number of shares of the Issuer's common stock issuable upon exercise of such Company Option, less applicable taxes and authorized deductions"},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of the Issuer's common stock granted under the Issuer's 2018 Omnibus Incentive Plan (f/k/a/ Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan) and the Axonics Modulation Technologies, Inc. 2014 Stock Incentive Plan (each such option, a \"Company Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (a) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Company Option and (b) the aggregate number of shares of the Issuer's common stock issuable upon exercise of such Company Option, less applicable taxes and authorized deductions"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Pursuant to the Merger Agreement, at the Effective Time, each outstanding and unexercised option to purchase shares of the Issuer's common stock granted under the Issuer's 2018 Omnibus Incentive Plan (f/k/a/ Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan) and the Axonics Modulation Technologies, Inc. 2014 Stock Incentive Plan (each such option, a \"Company Option\"), whether vested or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (a) the amount by which the Merger Consideration exceeds the exercise price per share applicable to such Company Option and (b) the aggregate number of shares of the Issuer's common stock issuable upon exercise of such Company Option, less applicable taxes and authorized deductions"}],"balance_after":0,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":196451},"source":{"system":"sec-edgar","filing":"0001562180-24-007702","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024007702/primarydocument.xml","form_type":"4"}},{"id":1363466,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2024-11-15T13:59:03.000Z","date":"2024-11-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":31125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of the Issuer's common stock, subject to the conditions set forth in the award agreement.  Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to be earned by the reporting person ranged from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total stockholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2025, and provided the reporting person remains in continuous service through January 31, 2025."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of the Issuer's common stock, subject to the conditions set forth in the award agreement.  Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to be earned by the reporting person ranged from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total stockholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2025, and provided the reporting person remains in continuous service through January 31, 2025."},{"field":"kind","element":"transactionCoding","label":"F4","text":"Pursuant the Merge Agreement, at the Effective Time, each outstanding Performance-Based Restricted Stock Unit granted under the Issuer's 2018 Omnibus Incentive Plan (f/k/a/ Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan) and the Axonics Modulation Technologies, Inc. 2014 Stock Incentive Plan for which the market condition is relative total stockholder return, whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration and (b) the aggregate number of shares underlying such Performance-Based Restricted Stock Unit (based on the actual  performance of the relevant peer group as of the Company's fiscal quarter-end immediately preceding the Effective Time and the Merger Consideration as the per share price), less applicable taxes and authorized deductions."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant the Merge Agreement, at the Effective Time, each outstanding Performance-Based Restricted Stock Unit granted under the Issuer's 2018 Omnibus Incentive Plan (f/k/a/ Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan) and the Axonics Modulation Technologies, Inc. 2014 Stock Incentive Plan for which the market condition is relative total stockholder return, whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration and (b) the aggregate number of shares underlying such Performance-Based Restricted Stock Unit (based on the actual  performance of the relevant peer group as of the Company's fiscal quarter-end immediately preceding the Effective Time and the Merger Consideration as the per share price), less applicable taxes and authorized deductions."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of the Issuer's common stock, subject to the conditions set forth in the award agreement.  Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to be earned by the reporting person ranged from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total stockholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2025, and provided the reporting person remains in continuous service through January 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant the Merge Agreement, at the Effective Time, each outstanding Performance-Based Restricted Stock Unit granted under the Issuer's 2018 Omnibus Incentive Plan (f/k/a/ Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan) and the Axonics Modulation Technologies, Inc. 2014 Stock Incentive Plan for which the market condition is relative total stockholder return, whether vested but unsettled or unvested, was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration and (b) the aggregate number of shares underlying such Performance-Based Restricted Stock Unit (based on the actual  performance of the relevant peer group as of the Company's fiscal quarter-end immediately preceding the Effective Time and the Merger Consideration as the per share price), less applicable taxes and authorized deductions."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":31125},"source":{"system":"sec-edgar","filing":"0001562180-24-007702","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024007702/primarydocument.xml","form_type":"4"}},{"id":1363465,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-11-15T13:59:03.000Z","date":"2024-11-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":292731,"price":71,"value":20783901.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the disposition of the reporting person's shares of the Issuer's common stock, upon the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 8, 2024 (the \"Merger Agreement\"), among the Issuer, Boston Scientific Corporation (\"Parent\") and Sadie Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger of Merger Sub with and into the Issuer with the Issuer as the surviving corporation (the \"Merger\").  Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective time\"), each outstanding share of the Issuer's common stock was canceled and converted automatically into the right to receive $71.00 in cash, without interest (The \"Merger Consideration\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares of the Issuer's common stock reported as disposed by the reporting person include restricted stock awards. Pursuant to the Merger Agreement, at the Effective Time, each outstanding restricted stock award granted under the Issuer's 2018 Omnibus Incentive Plan (f/k/a/ Axonics Modulation Technologies, Inc. 2018 Omnibus Incentive Plan) and the Axonics Modulation Technologies, Inc. 2014 Stock Incentive Plan was canceled and converted into the right to receive an amount in cash, without interest, equal to the product of (a) the Merger Consideration and (b) the aggregate number of shares subject to such restricted stock award, less applicable taxes and authorized deductions."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the disposition of the reporting person's shares of the Issuer's common stock, upon the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of January 8, 2024 (the \"Merger Agreement\"), among the Issuer, Boston Scientific Corporation (\"Parent\") and Sadie Merger Sub, Inc., a wholly owned subsidiary of Parent (\"Merger Sub\"), including the consummation of the merger of Merger Sub with and into the Issuer with the Issuer as the surviving corporation (the \"Merger\").  Pursuant to the Merger Agreement, at the effective time of the Merger (the \"Effective time\"), each outstanding share of the Issuer's common stock was canceled and converted automatically into the right to receive $71.00 in cash, without interest (The \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001562180-24-007702","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024007702/primarydocument.xml","form_type":"4"}},{"id":1448631,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-25T23:33:04.000Z","date":"2024-07-24","kind":"exercise","planned":false,"acquired":false,"shares":25771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on January 30, 2019 and are fully vested."}],"balance_after":196451,"derivative":{"exercise_price":14.19,"expiration_date":"2029-01-30","underlying":"Common Stock","underlying_shares":25771},"source":{"system":"sec-edgar","filing":"0001562180-24-005843","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024005843/primarydocument.xml","form_type":"4"}},{"id":1448630,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-07-25T23:33:04.000Z","date":"2024-07-24","kind":"exercise","planned":false,"acquired":false,"shares":78125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted on December 12, 2019 and are fully vested."}],"balance_after":0,"derivative":{"exercise_price":25.82,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":78125},"source":{"system":"sec-edgar","filing":"0001562180-24-005843","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024005843/primarydocument.xml","form_type":"4"}},{"id":1448629,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-25T23:33:04.000Z","date":"2024-07-24","kind":"exercise","planned":false,"acquired":true,"shares":78125,"price":25.82,"value":2017187.5,"ownership":{"direct":true},"balance_after":292731,"source":{"system":"sec-edgar","filing":"0001562180-24-005843","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024005843/primarydocument.xml","form_type":"4"}},{"id":1448628,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-25T23:33:04.000Z","date":"2024-07-24","kind":"exercise","planned":false,"acquired":true,"shares":25771,"price":14.19,"value":365690.49,"ownership":{"direct":true},"balance_after":214606,"source":{"system":"sec-edgar","filing":"0001562180-24-005843","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024005843/primarydocument.xml","form_type":"4"}},{"id":1661293,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2024-02-02T22:59:11.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":41500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024."}],"balance_after":0,"derivative":{"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":41500},"source":{"system":"sec-edgar","filing":"0001562180-24-001009","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024001009/primarydocument.xml","form_type":"4"}},{"id":1661292,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2024-02-02T22:59:11.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":false,"shares":21900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024."}],"balance_after":0,"derivative":{"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":21900},"source":{"system":"sec-edgar","filing":"0001562180-24-001009","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024001009/primarydocument.xml","form_type":"4"}},{"id":1661291,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-02T22:59:11.000Z","date":"2024-01-31","kind":"sale","planned":false,"acquired":false,"shares":35161,"price":67.7359,"value":2381661.9799,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the vesting of Performance-Based Restricted Stock Units disclosed herein and the vesting of Restricted Stock Awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $67.53 to $68.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":188835,"source":{"system":"sec-edgar","filing":"0001562180-24-001009","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024001009/primarydocument.xml","form_type":"4"}},{"id":1661290,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-02T22:59:11.000Z","date":"2024-01-31","kind":"exercise","planned":false,"acquired":true,"shares":63400,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":223996,"source":{"system":"sec-edgar","filing":"0001562180-24-001009","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218024001009/primarydocument.xml","form_type":"4"}},{"id":2013327,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-16T01:02:53.000Z","date":"2022-07-20","kind":"gift","acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":152596,"source":{"system":"sec-edgar","filing":"0001562180-23-001435","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023001435/primarydocument.xml","form_type":"5"}},{"id":2035572,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-02-03T01:06:32.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2023, and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2023, and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2023, and provided the reporting person remains in continuous service through January 31, 2023."}],"balance_after":0,"derivative":{"exercise_date":"2023-01-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001562180-23-000873","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000873/primarydocument.xml","form_type":"4"}},{"id":2035571,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-02-03T01:06:32.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":21968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."}],"balance_after":0,"derivative":{"exercise_date":"2023-01-31","underlying":"Common Stock","underlying_shares":21968},"source":{"system":"sec-edgar","filing":"0001562180-23-000873","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000873/primarydocument.xml","form_type":"4"}},{"id":2035570,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-02-03T01:06:32.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":20750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2025, and provided the reporting person remains in continuous service through January 31, 2025."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2025, and provided the reporting person remains in continuous service through January 31, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2025, and provided the reporting person remains in continuous service through January 31, 2025."}],"balance_after":20750,"derivative":{"exercise_date":"2025-01-31","underlying":"Common Stock","underlying_shares":20750},"source":{"system":"sec-edgar","filing":"0001562180-23-000873","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000873/primarydocument.xml","form_type":"4"}},{"id":2035569,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2023-02-03T01:06:32.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":41500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023 and provided the reporting person remains in continuous service through January 31, 2024."}],"balance_after":41500,"derivative":{"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":41500},"source":{"system":"sec-edgar","filing":"0001562180-23-000873","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000873/primarydocument.xml","form_type":"4"}},{"id":2035568,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-03T01:06:32.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":6932,"price":61.016,"value":422962.912,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $60.85 to $61.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":160596,"source":{"system":"sec-edgar","filing":"0001562180-23-000873","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000873/primarydocument.xml","form_type":"4"}},{"id":2035567,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-03T01:06:32.000Z","date":"2023-02-01","kind":"sale","acquired":false,"shares":1185,"price":60.4347,"value":71615.1195,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $59.85 to $60.845. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":167528,"source":{"system":"sec-edgar","filing":"0001562180-23-000873","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000873/primarydocument.xml","form_type":"4"}},{"id":2035566,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-03T01:06:32.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":9032,"price":61.1219,"value":552053.0008,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $60.78 to $61.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":168713,"source":{"system":"sec-edgar","filing":"0001562180-23-000873","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000873/primarydocument.xml","form_type":"4"}},{"id":2035565,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-03T01:06:32.000Z","date":"2023-01-31","kind":"sale","acquired":false,"shares":13872,"price":61.1694,"value":848541.9168,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $60.78 to $61.595. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":177745,"source":{"system":"sec-edgar","filing":"0001562180-23-000873","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000873/primarydocument.xml","form_type":"4"}},{"id":2035564,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-03T01:06:32.000Z","date":"2023-01-31","kind":"exercise","acquired":true,"shares":61968,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":191617,"source":{"system":"sec-edgar","filing":"0001562180-23-000873","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000873/primarydocument.xml","form_type":"4"}},{"id":2035563,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-02-03T01:06:32.000Z","date":"2023-01-31","kind":"grant","acquired":true,"shares":20750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":129649,"source":{"system":"sec-edgar","filing":"0001562180-23-000873","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000873/primarydocument.xml","form_type":"4"}},{"id":2052222,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-19T01:04:00.000Z","date":"2023-01-13","kind":"sale","acquired":false,"shares":22052,"price":66.2722,"value":1461434.5544,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $66.00 to $66.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":108899,"source":{"system":"sec-edgar","filing":"0001562180-23-000495","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000495/primarydocument.xml","form_type":"4"}},{"id":2052221,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-01-19T01:04:00.000Z","date":"2023-01-13","kind":"sale","acquired":false,"shares":18684,"price":65.5409,"value":1224566.1756,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $65.00 to $65.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":130951,"source":{"system":"sec-edgar","filing":"0001562180-23-000495","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218023000495/primarydocument.xml","form_type":"4"}},{"id":2189237,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-10T23:29:03.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":1776,"price":72.0873,"value":128027.0448,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $71.97 to $72.54. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":149635,"source":{"system":"sec-edgar","filing":"0001562180-22-006035","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022006035/primarydocument.xml","form_type":"4"}},{"id":2189236,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-10T23:29:03.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":12032,"price":71.6504,"value":862097.6128,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $70.95 to $71.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":151411,"source":{"system":"sec-edgar","filing":"0001562180-22-006035","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022006035/primarydocument.xml","form_type":"4"}},{"id":2189235,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-10T23:29:03.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":12092,"price":70.4015,"value":851294.938,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $69.95 to $70.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":163443,"source":{"system":"sec-edgar","filing":"0001562180-22-006035","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022006035/primarydocument.xml","form_type":"4"}},{"id":2189234,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-08-10T23:29:03.000Z","date":"2022-08-08","kind":"sale","acquired":false,"shares":18100,"price":69.4976,"value":1257906.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $68.95 to $69.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":175535,"source":{"system":"sec-edgar","filing":"0001562180-22-006035","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022006035/primarydocument.xml","form_type":"4"}},{"id":2312691,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-04-01T00:04:41.000Z","date":"2022-03-29","kind":"sale","acquired":false,"shares":50000,"price":60,"value":3000000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person."}],"balance_after":193635,"source":{"system":"sec-edgar","filing":"0001562180-22-003045","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022003045/primarydocument.xml","form_type":"4"}},{"id":2330453,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-17T01:13:01.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":16900,"price":54.7986,"value":926096.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $54.09 to $55.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":243635,"source":{"system":"sec-edgar","filing":"0001562180-22-002687","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022002687/primarydocument.xml","form_type":"4"}},{"id":2330452,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-17T01:13:01.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":11232,"price":53.9533,"value":606003.4656,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $53.09 to $54.05. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":260535,"source":{"system":"sec-edgar","filing":"0001562180-22-002687","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022002687/primarydocument.xml","form_type":"4"}},{"id":2330451,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-17T01:13:01.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":1981,"price":52.6584,"value":104316.2904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $52.05 to $53.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":271767,"source":{"system":"sec-edgar","filing":"0001562180-22-002687","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022002687/primarydocument.xml","form_type":"4"}},{"id":2330450,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-17T01:13:01.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":2100,"price":51.4001,"value":107940.21,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $51.02 to $52.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":273748,"source":{"system":"sec-edgar","filing":"0001562180-22-002687","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022002687/primarydocument.xml","form_type":"4"}},{"id":2330449,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-03-17T01:13:01.000Z","date":"2022-03-14","kind":"sale","acquired":false,"shares":17787,"price":50.4184,"value":896792.0808,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":275848,"source":{"system":"sec-edgar","filing":"0001562180-22-002687","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022002687/primarydocument.xml","form_type":"4"}},{"id":2394160,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-16T00:21:37.000Z","date":"2021-09-30","kind":"gift","acquired":false,"shares":28000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":293635,"source":{"system":"sec-edgar","filing":"0001562180-22-001499","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001499/primarydocument.xml","form_type":"5"}},{"id":2394159,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-16T00:21:37.000Z","date":"2021-07-02","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":321635,"source":{"system":"sec-edgar","filing":"0001562180-22-001499","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001499/primarydocument.xml","form_type":"5"}},{"id":2394158,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-16T00:21:37.000Z","date":"2021-05-05","kind":"gift","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":326635,"source":{"system":"sec-edgar","filing":"0001562180-22-001499","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001499/primarydocument.xml","form_type":"5"}},{"id":2394157,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-16T00:21:37.000Z","date":"2021-02-05","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":329635,"source":{"system":"sec-edgar","filing":"0001562180-22-001499","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001499/primarydocument.xml","form_type":"5"}},{"id":2394156,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-16T00:21:37.000Z","date":"2021-01-08","kind":"gift","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":334635,"source":{"system":"sec-edgar","filing":"0001562180-22-001499","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001499/primarydocument.xml","form_type":"5"}},{"id":2413292,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-02-04T02:30:38.000Z","date":"2022-02-03","kind":"exercise","acquired":false,"shares":54346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2021, and provided the reporting person remains in continuous service through December 31, 2021."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2021, and provided the reporting person remains in continuous service through December 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2021, and provided the reporting person remains in continuous service through December 31, 2021."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2021-12-31","underlying":"Common Stock","underlying_shares":54346},"source":{"system":"sec-edgar","filing":"0001562180-22-001104","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001104/primarydocument.xml","form_type":"4"}},{"id":2413291,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-02-04T02:30:38.000Z","date":"2022-02-03","kind":"exercise","acquired":false,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022."}],"balance_after":0,"derivative":{"exercise_date":"2022-01-31","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001562180-22-001104","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001104/primarydocument.xml","form_type":"4"}},{"id":2413290,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-02-04T02:30:38.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":10950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2024, and provided the reporting person remains in continuous service through January 31, 2024."}],"balance_after":10950,"derivative":{"exercise_date":"2024-01-31","underlying":"Common Stock","underlying_shares":10950},"source":{"system":"sec-edgar","filing":"0001562180-22-001104","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001104/primarydocument.xml","form_type":"4"}},{"id":2413289,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2022-02-04T02:30:38.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":21968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2022 and provided the reporting person remains in continuous service through January 31, 2023."}],"balance_after":21968,"derivative":{"exercise_date":"2023-01-31","underlying":"Common Stock","underlying_shares":21968},"source":{"system":"sec-edgar","filing":"0001562180-22-001104","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001104/primarydocument.xml","form_type":"4"}},{"id":2413288,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-04T02:30:38.000Z","date":"2022-02-03","kind":"sale","acquired":false,"shares":1779,"price":49.0347,"value":87232.7313,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $48.78 to $49.14. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":339635,"source":{"system":"sec-edgar","filing":"0001562180-22-001104","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001104/primarydocument.xml","form_type":"4"}},{"id":2413287,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-04T02:30:38.000Z","date":"2022-02-03","kind":"sale","acquired":false,"shares":33336,"price":48.2103,"value":1607138.5608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $47.76 to $48.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":341414,"source":{"system":"sec-edgar","filing":"0001562180-22-001104","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001104/primarydocument.xml","form_type":"4"}},{"id":2413286,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-04T02:30:38.000Z","date":"2022-02-03","kind":"exercise","acquired":true,"shares":96846,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":374750,"source":{"system":"sec-edgar","filing":"0001562180-22-001104","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001104/primarydocument.xml","form_type":"4"}},{"id":2413285,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-02-04T02:30:38.000Z","date":"2022-01-31","kind":"grant","acquired":true,"shares":43297,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":277904,"source":{"system":"sec-edgar","filing":"0001562180-22-001104","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218022001104/primarydocument.xml","form_type":"4"}},{"id":2571863,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-09-14T00:59:19.000Z","date":"2021-09-09","kind":"sale","acquired":false,"shares":50000,"price":77.107,"value":3855350.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $77.0935 to $77.1178. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":234607,"source":{"system":"sec-edgar","filing":"0001562180-21-005938","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021005938/primarydocument.xml","form_type":"4"}},{"id":2634442,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-07-15T00:00:56.000Z","date":"2021-07-12","kind":"grant","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan."}],"balance_after":27763,"source":{"system":"sec-edgar","filing":"0001437749-21-016942","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774921016942/rdgdoc.xml","form_type":"4"}},{"id":2673680,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-06-11T01:37:48.000Z","date":"2021-06-08","kind":"sale","acquired":false,"shares":33333,"price":60,"value":1999980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":284607,"source":{"system":"sec-edgar","filing":"0001562180-21-004197","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021004197/primarydocument.xml","form_type":"4"}},{"id":2702797,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-21T01:09:55.000Z","date":"2021-05-18","kind":"sale","acquired":false,"shares":32833,"price":55,"value":1805815.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."}],"balance_after":317940,"source":{"system":"sec-edgar","filing":"0001562180-21-003684","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021003684/primarydocument.xml","form_type":"4"}},{"id":2716106,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-13T00:31:17.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":2770,"price":54.8102,"value":151824.254,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $54.60 to $55.495. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":350773,"source":{"system":"sec-edgar","filing":"0001562180-21-003441","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021003441/primarydocument.xml","form_type":"4"}},{"id":2716105,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-13T00:31:17.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":17954,"price":54.1271,"value":971797.9534,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $53.595 to $54.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":353543,"source":{"system":"sec-edgar","filing":"0001562180-21-003441","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021003441/primarydocument.xml","form_type":"4"}},{"id":2716104,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-05-13T00:31:17.000Z","date":"2021-05-10","kind":"sale","acquired":false,"shares":13109,"price":52.9816,"value":694535.7944,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $52.58 to $53.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":371497,"source":{"system":"sec-edgar","filing":"0001562180-21-003441","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021003441/primarydocument.xml","form_type":"4"}},{"id":2862819,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-13T00:12:00.000Z","date":"2020-09-15","kind":"gift","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":384606,"source":{"system":"sec-edgar","filing":"0001562180-21-001142","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021001142/primarydocument.xml","form_type":"5"}},{"id":2862818,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-13T00:12:00.000Z","date":"2020-08-18","kind":"gift","acquired":false,"shares":45490,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":409606,"source":{"system":"sec-edgar","filing":"0001562180-21-001142","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021001142/primarydocument.xml","form_type":"5"}},{"id":2862817,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-13T00:12:00.000Z","date":"2020-04-28","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":455096,"source":{"system":"sec-edgar","filing":"0001562180-21-001142","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021001142/primarydocument.xml","form_type":"5"}},{"id":2885098,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2021-02-03T01:50:39.000Z","date":"2021-02-01","kind":"exercise","acquired":false,"shares":16667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2020, and provided the reporting person remains in continuous service through January 30, 2021. The awards were earned at 200% of the target number on January 31, 2021."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2020, and provided the reporting person remains in continuous service through January 30, 2021. The awards were earned at 200% of the target number on January 31, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2020, and provided the reporting person remains in continuous service through January 30, 2021. The awards were earned at 200% of the target number on January 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2020, and provided the reporting person remains in continuous service through January 30, 2021. The awards were earned at 200% of the target number on January 31, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33334},"source":{"system":"sec-edgar","filing":"0001562180-21-000757","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021000757/primarydocument.xml","form_type":"4"}},{"id":2885097,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2021-02-03T01:50:39.000Z","date":"2021-01-31","kind":"grant","acquired":true,"shares":42500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2021 and provided the reporting person remains in continuous service through January 31, 2022."}],"balance_after":42500,"derivative":{"exercise_date":"2023-01-31","underlying":"Common Stock","underlying_shares":42500},"source":{"system":"sec-edgar","filing":"0001562180-21-000757","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021000757/primarydocument.xml","form_type":"4"}},{"id":2885096,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2021-02-03T01:50:39.000Z","date":"2021-01-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2023, and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2023, and provided the reporting person remains in continuous service through January 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending January 31, 2023, and provided the reporting person remains in continuous service through January 31, 2023."}],"balance_after":20000,"derivative":{"exercise_date":"2022-01-31","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-21-000757","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021000757/primarydocument.xml","form_type":"4"}},{"id":2885095,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T01:50:39.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":952,"price":52.1179,"value":49616.2408,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $52.04 to $52.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":456096,"source":{"system":"sec-edgar","filing":"0001562180-21-000757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021000757/primarydocument.xml","form_type":"4"}},{"id":2885094,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T01:50:39.000Z","date":"2021-02-01","kind":"sale","acquired":false,"shares":12675,"price":51.3645,"value":651045.0375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $51.03 to $52.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":457048,"source":{"system":"sec-edgar","filing":"0001562180-21-000757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021000757/primarydocument.xml","form_type":"4"}},{"id":2885093,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T01:50:39.000Z","date":"2021-02-01","kind":"exercise","acquired":true,"shares":33334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The number of Performance-Based Restricted Stock Units represents the target number of Performance-Based Restricted Stock Units that were granted to the reporting person on the date of grant, each of which represents the contingent right to receive one share of common stock, subject to the conditions set forth in the award agreement. Per the terms of the award agreement governing the Performance-Based Restricted Stock Units, the number of Performance-Based Restricted Stock Units to which the reporting person may ultimately become entitled ranges from 0% to 200% of the target number of Performance-Based Restricted Stock Units granted, based upon the total shareholder return of the Issuer's common stock relative to its peer group index over a performance period consisting of the two fiscal years ending December 31, 2020, and provided the reporting person remains in continuous service through January 30, 2021. The awards were earned at 200% of the target number on January 31, 2021."}],"balance_after":469723,"source":{"system":"sec-edgar","filing":"0001562180-21-000757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021000757/primarydocument.xml","form_type":"4"}},{"id":2885092,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-02-03T01:50:39.000Z","date":"2021-01-31","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":436389,"source":{"system":"sec-edgar","filing":"0001562180-21-000757","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021000757/primarydocument.xml","form_type":"4"}},{"id":2893338,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Performance-Based Restricted Stock Units","published_at":"2021-01-28T01:08:43.000Z","date":"2021-01-26","kind":"exercise","acquired":false,"shares":27173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2020 and provided the reporting person remains in continuous service through December 31, 2020."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2020 and provided the reporting person remains in continuous service through December 31, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2020 and provided the reporting person remains in continuous service through December 31, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2020 and provided the reporting person remains in continuous service through December 31, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27173},"source":{"system":"sec-edgar","filing":"0001562180-21-000565","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021000565/primarydocument.xml","form_type":"4"}},{"id":2893337,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-28T01:08:43.000Z","date":"2021-01-26","kind":"sale","acquired":false,"shares":7842,"price":53.5766,"value":420147.6972,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $53.14 to $53.96. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":416389,"source":{"system":"sec-edgar","filing":"0001562180-21-000565","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021000565/primarydocument.xml","form_type":"4"}},{"id":2893336,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-01-28T01:08:43.000Z","date":"2021-01-26","kind":"exercise","acquired":true,"shares":27173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2020 and provided the reporting person remains in continuous service through December 31, 2020."}],"balance_after":424231,"source":{"system":"sec-edgar","filing":"0001562180-21-000565","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218021000565/primarydocument.xml","form_type":"4"}},{"id":2980346,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-17T02:22:15.000Z","date":"2020-11-12","kind":"sale","acquired":false,"shares":5625,"price":32.45,"value":182531.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.36 to $32.60, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":22763,"source":{"system":"sec-edgar","filing":"0001437749-20-024047","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774920024047/rdgdoc.xml","form_type":"4"}},{"id":3011228,"issuer":{"id":4614,"kind":"organization","name":"BIOLIFE SOLUTIONS INC","symbol":"BLFS"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-10-08T00:30:24.000Z","date":"2020-10-05","kind":"grant","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date."}],"balance_after":28388,"source":{"system":"sec-edgar","filing":"0001437749-20-020869","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/834365/000143774920020869/rdgdoc.xml","form_type":"4"}},{"id":3061701,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-12T00:32:12.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":11033,"price":42.776,"value":471947.608,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $42.42 to $43.08. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":397058,"source":{"system":"sec-edgar","filing":"0001562180-20-005394","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005394/primarydocument.xml","form_type":"4"}},{"id":3061700,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-12T00:32:12.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":8808,"price":42.0534,"value":370406.3472,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $41.42 to $42.415. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":408091,"source":{"system":"sec-edgar","filing":"0001562180-20-005394","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005394/primarydocument.xml","form_type":"4"}},{"id":3061699,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-12T00:32:12.000Z","date":"2020-08-11","kind":"sale","acquired":false,"shares":5159,"price":40.9541,"value":211282.2019,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $40.41 to $41.325. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":416899,"source":{"system":"sec-edgar","filing":"0001562180-20-005394","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005394/primarydocument.xml","form_type":"4"}},{"id":3061698,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-12T00:32:12.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":3367,"price":42.7455,"value":143924.0985,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $42.6125 to $42.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":422058,"source":{"system":"sec-edgar","filing":"0001562180-20-005394","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005394/primarydocument.xml","form_type":"4"}},{"id":3061697,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-08-12T00:32:12.000Z","date":"2020-08-07","kind":"sale","acquired":false,"shares":16633,"price":41.824,"value":695658.592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $41.525 to $42.28. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":425425,"source":{"system":"sec-edgar","filing":"0001562180-20-005394","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005394/primarydocument.xml","form_type":"4"}},{"id":3080261,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-17T23:38:53.000Z","date":"2020-07-16","kind":"sale","acquired":false,"shares":25000,"price":39.6507,"value":991267.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $39.41 to $39.685. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":442058,"source":{"system":"sec-edgar","filing":"0001562180-20-005180","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005180/primarydocument.xml","form_type":"4"}},{"id":3080260,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-17T23:38:53.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":900,"price":39.9372,"value":35943.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $39.92 to $39.97. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":467058,"source":{"system":"sec-edgar","filing":"0001562180-20-005180","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005180/primarydocument.xml","form_type":"4"}},{"id":3080259,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-17T23:38:53.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":15472,"price":39.6073,"value":612804.1456,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $38.92 to $39.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":467958,"source":{"system":"sec-edgar","filing":"0001562180-20-005180","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005180/primarydocument.xml","form_type":"4"}},{"id":3080258,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-17T23:38:53.000Z","date":"2020-07-15","kind":"sale","acquired":false,"shares":8628,"price":38.5465,"value":332579.202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $37.905 to $38.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":483430,"source":{"system":"sec-edgar","filing":"0001562180-20-005180","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005180/primarydocument.xml","form_type":"4"}},{"id":3082532,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-16T01:55:28.000Z","date":"2020-07-14","kind":"sale","acquired":false,"shares":25000,"price":36.4909,"value":912272.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $36.114 to $36.625. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":492058,"source":{"system":"sec-edgar","filing":"0001562180-20-005129","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005129/primarydocument.xml","form_type":"4"}},{"id":3082531,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-16T01:55:28.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":200,"price":41.1,"value":8220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."}],"balance_after":517058,"source":{"system":"sec-edgar","filing":"0001562180-20-005129","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005129/primarydocument.xml","form_type":"4"}},{"id":3082530,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-07-16T01:55:28.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":24800,"price":40.3444,"value":1000541.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on June 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $40.00 to $40.92. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":517258,"source":{"system":"sec-edgar","filing":"0001562180-20-005129","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020005129/primarydocument.xml","form_type":"4"}},{"id":3202149,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-03-18T22:00:24.000Z","date":"2020-03-16","kind":"exercise","acquired":false,"shares":41224,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest over a period of four years. 42,000 of the shares subject to the option vested on March 30, 2018 and the remainder vest at a rate of 1/36th per month commencing on March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":106776,"derivative":{"exercise_price":1.63,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":41224},"source":{"system":"sec-edgar","filing":"0001562180-20-002629","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020002629/primarydocument.xml","form_type":"4"}},{"id":3202148,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-18T22:00:24.000Z","date":"2020-03-16","kind":"sale","acquired":false,"shares":6955,"price":21.4795,"value":149389.9225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on September 25, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $21.30 to $21.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":542058,"source":{"system":"sec-edgar","filing":"0001562180-20-002629","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020002629/primarydocument.xml","form_type":"4"}},{"id":3202147,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-18T22:00:24.000Z","date":"2020-03-16","kind":"sale","acquired":false,"shares":34269,"price":20.8716,"value":715248.8604,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on September 25, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $20.30 to $21.295. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":549013,"source":{"system":"sec-edgar","filing":"0001562180-20-002629","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020002629/primarydocument.xml","form_type":"4"}},{"id":3202146,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-03-18T22:00:24.000Z","date":"2020-03-16","kind":"exercise","acquired":true,"shares":41224,"price":1.63,"value":67195.12,"ownership":{"direct":true},"balance_after":583282,"source":{"system":"sec-edgar","filing":"0001562180-20-002629","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020002629/primarydocument.xml","form_type":"4"}},{"id":3266452,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-19T01:32:05.000Z","date":"2020-02-13","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest over a period of four years.  42,000 of the shares subject to the option vested on March 30, 2018 and the remainder vest at a rate of 1/36th per month commencing on March 30, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer. The option is subject to an early exercise provision and is immediately exercisable."}],"balance_after":148000,"derivative":{"exercise_price":1.63,"expiration_date":"2028-03-30","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-20-001321","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020001321/primarydocument.xml","form_type":"4"}},{"id":3266451,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-19T01:32:05.000Z","date":"2020-02-13","kind":"sale","acquired":false,"shares":10000,"price":33.2065,"value":332065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was pursuant to a 10b5-1 plan adopted by the reporting person on September 25, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $32.74 to $33.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":542058,"source":{"system":"sec-edgar","filing":"0001562180-20-001321","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020001321/primarydocument.xml","form_type":"4"}},{"id":3266450,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-19T01:32:05.000Z","date":"2020-02-13","kind":"exercise","acquired":true,"shares":10000,"price":1.63,"value":16300.0,"ownership":{"direct":true},"balance_after":552058,"source":{"system":"sec-edgar","filing":"0001562180-20-001321","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020001321/primarydocument.xml","form_type":"4"}},{"id":3270245,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-15T02:55:30.000Z","date":"2019-06-19","kind":"gift","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":542058,"source":{"system":"sec-edgar","filing":"0001562180-20-001262","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020001262/primarydocument.xml","form_type":"5"}},{"id":3270244,"issuer":{"id":86004,"kind":"organization","name":"Axonics, Inc.","symbol":"AXNX"},"owners":[{"id":36916,"kind":"person","name":"COHEN RAYMOND W","position":1,"cik":"0001258288","reported_name":"COHEN RAYMOND W","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2020-02-15T02:55:30.000Z","date":"2019-06-18","kind":"gift","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":557058,"source":{"system":"sec-edgar","filing":"0001562180-20-001262","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1258288/000156218020001262/primarydocument.xml","form_type":"5"}}],"next_cursor":"2020-02-15T02:55:30.000000Z,3270244"}